Associations Between Pre‐Existing Cardiovascular Disease and Survival in Patients on Immune Checkpoint Inhibitor Therapy

Documenti analoghi

• Associations between language, telehealth, and clinical outcomes in patients with cancer during the COVID ‐19 pandemic
  di: Armon Azizi, et al.
  Pubblicazione: (2024)
• Concomitant Usage of H1‐Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival
  di: Yin Leung, et al.
  Pubblicazione: (2025)
• TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer
  di: Zenta Seto, et al.
  Pubblicazione: (2025)
• Comparison of the Immune Checkpoint Inhibitor‐Free Survival Between Patients Who Completed and Those Who Discontinued ICI for Non‐Small Cell Lung Cancer
  di: Takahiro Nagai, et al.
  Pubblicazione: (2025)
• Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
  di: Ling Chen, et al.
  Pubblicazione: (2024)